in this issue
World News and Views :: Top of the News
AMRI extends API supply deal with Shire
8:34 AM MDT | October 19, 2012 | Deepti Ramesh
Albany Molecular Research Inc. (AMRI; Albany) says it has entered into a mult-year active pharmaceutical ingredient (API) supply agreement for an undisclosed product with Shire US Manufacturing (Owings Mills, MD), a subsidiary of specialty biopharmaceutical company Shire (Dublin). The terms of the deal were not disclosed. The agreement extends a previously existing agreement between the two companies, AMRI says. Shire focuses its business on behavioral health, gastrointestinal diseases, rare diseases, and regenerative medicine, AMRI says. “We are pleased to...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee